These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24780472)

  • 1. Proteomics and metabolomics as tools to unravel novel culprits and mechanisms of uremic toxicity: instrument or hype?
    Mullen W; Saigusa D; Abe T; Adamski J; Mischak H
    Semin Nephrol; 2014 Mar; 34(2):180-90. PubMed ID: 24780472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Future Avenues to Decrease Uremic Toxin Concentration.
    Vanholder RC; Eloot S; Glorieux GL
    Am J Kidney Dis; 2016 Apr; 67(4):664-76. PubMed ID: 26500179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the uremic toxins using proteomic technologies.
    Schiffer E; Mischak H; Vanholder RC
    Contrib Nephrol; 2008; 160():159-171. PubMed ID: 18401168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New methods and technologies for measuring uremic toxins and quantifying dialysis adequacy.
    Vanholder R; Boelaert J; Glorieux G; Eloot S
    Semin Dial; 2015; 28(2):114-24. PubMed ID: 25441338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of EUTox in uremic toxin research.
    Vanholder R; Abou-Deif O; Argiles A; Baurmeister U; Beige J; Brouckaert P; Brunet P; Cohen G; De Deyn PP; Drüeke TB; Fliser D; Glorieux G; Herget-Rosenthal S; Hörl WH; Jankowski J; Jörres A; Massy ZA; Mischak H; Perna AF; Rodriguez-Portillo JM; Spasovski G; Stegmayr BG; Stenvinkel P; Thornalley PJ; Wanner C; Wiecek A
    Semin Dial; 2009; 22(4):323-8. PubMed ID: 19708975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uremic toxins: a new focus on an old subject.
    Yavuz A; Tetta C; Ersoy FF; D'intini V; Ratanarat R; De Cal M; Bonello M; Bordoni V; Salvatori G; Andrikos E; Yakupoglu G; Levin NW; Ronco C
    Semin Dial; 2005; 18(3):203-11. PubMed ID: 15934967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uremic toxins: do we know enough to explain uremia?
    Vanholder R; Meert N; Schepers E; Glorieux G
    Blood Purif; 2008; 26(1):77-81. PubMed ID: 18182802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update of uremic toxin research by mass spectrometry.
    Niwa T
    Mass Spectrom Rev; 2011; 30(3):510-21. PubMed ID: 21328600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical studies and chronic kidney disease: what did we learn recently?
    Liabeuf S; Neirynck N; Drüeke TB; Vanholder R; Massy ZA
    Semin Nephrol; 2014 Mar; 34(2):164-79. PubMed ID: 24780471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Update on proteomic use in hemodialysis].
    Bonomini M; Sirolli V; Baroni S; Urbani A
    G Ital Nefrol; 2017 Aug; 34(4):28-34. PubMed ID: 28762680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should dialysis modalities be designed to remove specific uremic toxins?
    Baurmeister U; Vienken J; Ward RA
    Semin Dial; 2009; 22(4):454-7. PubMed ID: 19709001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracorporeal removal of uremic toxins: can we still do better?
    Eloot S; Ledebo I; Ward RA
    Semin Nephrol; 2014 Mar; 34(2):209-27. PubMed ID: 24780474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomics and Metabolomics in Kidney Disease, including Insights into Etiology, Treatment, and Prevention.
    Dubin RF; Rhee EP
    Clin J Am Soc Nephrol; 2020 Mar; 15(3):404-411. PubMed ID: 31636087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A bench to bedside view of uremic toxins.
    Vanholder R; Baurmeister U; Brunet P; Cohen G; Glorieux G; Jankowski J;
    J Am Soc Nephrol; 2008 May; 19(5):863-70. PubMed ID: 18287557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results of proteomic-based study of the kidney, urine, plasma, and uremic ultrafiltrate. Potential applications of the results in nephrology].
    Opatrný K
    Vnitr Lek; 2004 Jul; 50(7):556-63. PubMed ID: 15323265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [On-line HFR and removal of uremic toxins inducing the loss of phospholipidic asymmetry of the erythrocyte membrane].
    Sirolli V; Cappelli P; Amoroso L; Di Liberato L; Muscianese P; Santarelli P; Del Rosso G; Bonomini M
    G Ital Nefrol; 2004; 21 Suppl 30():S208-11. PubMed ID: 15750987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uremic toxins: what are they? An integrated overview of pathobiology and classification.
    Glassock RJ
    J Ren Nutr; 2008 Jan; 18(1):2-6. PubMed ID: 18089436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebro-renal interactions: impact of uremic toxins on cognitive function.
    Watanabe K; Watanabe T; Nakayama M
    Neurotoxicology; 2014 Sep; 44():184-93. PubMed ID: 25003961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From uremic toxin retention to removal by convection: do we know enough?
    Vanholder R; Meert N; Schepers E; Glorieux G
    Contrib Nephrol; 2008; 161():125-131. PubMed ID: 18451668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.